Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...
Cash, cash equivalents and marketable securities as of December 31, 2024, were $294.5 million. As a result, we expect our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback